SEC Advances Proposal to End Mandatory Quarterly Earnings Reports Backed by Trump CAPR Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline AbbVie Secures EU Approval for Expanded Venclyxto Label in Chronic Lymphocytic Leukemia